Publicaciones en las que colabora con MIGUEL DÍAZ HERNÁNDEZ (44)

2024

  1. Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 115-125

2018

  1. MicroRNA-22 controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus

    Frontiers in Molecular Neuroscience, Vol. 11

2017

  1. Neuronal P2X7 receptor: Involvement in neuronal physiology and

    Journal of Neuroscience, Vol. 37, Núm. 30, pp. 7063-7072

2016

  1. Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation

    Human Molecular Genetics, Vol. 25, Núm. 19, pp. 4143-4156

  2. Presynaptic P2X1-3 and α3-containing nicotinic receptors assemble into functionally interacting ion channels in the rat hippocampus

    Neuropharmacology, Vol. 105, pp. 241-257

2015

  1. Age-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1

    PLoS ONE, Vol. 10, Núm. 4

  2. MicroRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

    Scientific Reports, Vol. 5

  3. Role of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptor

    Computational and Structural Biotechnology Journal, Vol. 13, pp. 176-181

  4. TNAP plays a key role in neural differentiation as well as in neurodegenerative disorders

    Sub-Cellular Biochemistry, Vol. 76, pp. 375-385

  5. Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System during Development and Disease

    Computational and Structural Biotechnology Journal, Vol. 13, pp. 95-100

2014

  1. P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage

    CNS Neuroscience and Therapeutics, Vol. 20, Núm. 6, pp. 556-564

2013

  1. Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079

    Epilepsia, Vol. 54, Núm. 9, pp. 1551-1561

  2. P2X receptors as targets for the treatment of status epilepticus

    Frontiers in Cellular Neuroscience, Vol. 7, Núm. NOV

2012

  1. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation

    Journal of Cell Science, Vol. 125, Núm. 1, pp. 176-188

  2. In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases

    Neurobiology of Aging, Vol. 33, Núm. 8, pp. 1816-1828

  3. P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control

    International Journal of Physiology, Pathophysiology and Pharmacology, Vol. 4, Núm. 4, pp. 174-187

  4. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice

    FASEB Journal, Vol. 26, Núm. 4, pp. 1616-1628

  5. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

    Human Molecular Genetics, Vol. 21, Núm. 3, pp. 495-510

2011

  1. Opposite effects of P2X7 and P2Y2 nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells

    FEBS Letters, Vol. 585, Núm. 14, pp. 2255-2262

  2. Tissue-nonspecific alkaline phosphatase promotes axonal growth of hippocampal neurons

    Molecular Biology of the Cell, Vol. 22, Núm. 7, pp. 1014-1024